Chemours Future Growth
Future criteria checks 5/6
Chemours is forecast to grow earnings and revenue by 81.8% and 4.7% per annum respectively. EPS is expected to grow by 81.8% per annum. Return on equity is forecast to be 49.8% in 3 years.
Key information
81.8%
Earnings growth rate
81.8%
EPS growth rate
Chemicals earnings growth | 21.6% |
Revenue growth rate | 4.7% |
Future return on equity | 49.8% |
Analyst coverage | Good |
Last updated | 01 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,561 | 799 | 527 | 929 | 4 |
12/31/2025 | 6,431 | 532 | 270 | 719 | 8 |
12/31/2024 | 5,854 | 247 | -361 | 223 | 2 |
3/31/2024 | 5,841 | -331 | 9 | 390 | N/A |
12/31/2023 | 6,027 | -238 | 186 | 556 | N/A |
9/30/2023 | 6,004 | -309 | -70 | 232 | N/A |
6/30/2023 | 6,294 | -87 | 115 | 403 | N/A |
3/31/2023 | 6,566 | 489 | 341 | 633 | N/A |
12/31/2022 | 6,794 | 578 | 448 | 755 | N/A |
9/30/2022 | 7,031 | 908 | 485 | 808 | N/A |
6/30/2022 | 6,933 | 881 | 500 | 818 | N/A |
3/31/2022 | 6,673 | 746 | 460 | 783 | N/A |
12/31/2021 | 6,345 | 608 | 537 | 814 | N/A |
9/30/2021 | 6,108 | 394 | 712 | 959 | N/A |
6/30/2021 | 5,662 | 256 | 720 | 947 | N/A |
3/31/2021 | 5,100 | 215 | 581 | 802 | N/A |
12/31/2020 | 4,969 | 219 | 540 | 807 | N/A |
9/30/2020 | 4,984 | -117 | 544 | 854 | N/A |
6/30/2020 | 5,140 | -117 | 452 | 843 | N/A |
3/31/2020 | 5,455 | -46 | 284 | 738 | N/A |
12/31/2019 | 5,526 | -52 | 169 | 650 | N/A |
9/30/2019 | 5,637 | 407 | -30 | 509 | N/A |
6/30/2019 | 5,876 | 606 | 36 | 563 | N/A |
3/31/2019 | 6,284 | 792 | 371 | 900 | N/A |
12/31/2018 | 6,638 | 995 | 642 | 1,140 | N/A |
9/30/2018 | 6,749 | 1,081 | 675 | 1,184 | N/A |
6/30/2018 | 6,705 | 1,013 | 453 | 954 | N/A |
3/31/2018 | 6,476 | 893 | 351 | 795 | N/A |
12/31/2017 | 6,183 | 746 | N/A | 640 | N/A |
9/30/2017 | 5,930 | 288 | N/A | 607 | N/A |
6/30/2017 | 5,744 | 285 | N/A | 693 | N/A |
3/31/2017 | 5,540 | 106 | N/A | 599 | N/A |
12/31/2016 | 5,400 | 7 | N/A | 594 | N/A |
9/30/2016 | 5,438 | 151 | N/A | 626 | N/A |
6/30/2016 | 5,526 | -82 | N/A | 541 | N/A |
3/31/2016 | 5,651 | -82 | N/A | 456 | N/A |
12/31/2015 | 5,717 | -90 | N/A | 182 | N/A |
9/30/2015 | 5,906 | 75 | N/A | 372 | N/A |
6/30/2015 | 6,052 | 211 | N/A | 501 | N/A |
3/31/2015 | 6,226 | 345 | N/A | 541 | N/A |
12/31/2014 | 6,432 | 400 | N/A | 505 | N/A |
9/30/2014 | 6,539 | 431 | N/A | 543 | N/A |
12/31/2013 | 6,859 | 423 | N/A | 798 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0HWG is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).
Earnings vs Market: 0HWG is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0HWG is expected to become profitable in the next 3 years.
Revenue vs Market: 0HWG's revenue (4.7% per year) is forecast to grow faster than the UK market (3.4% per year).
High Growth Revenue: 0HWG's revenue (4.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0HWG's Return on Equity is forecast to be very high in 3 years time (49.8%).